Abstract:Background: Adefovir dipivoxil (ADV)-induced renal tubular dysfunction and hypophosphatemic osteomalacia (HO) have been given great consideration in the past few years. However, no standard guidance is available due to a lack of powerful evidence from appropriate long-term prospective case-control studies and variations in the definition of renal adverse events. The aim of this study is to clarify clinical features of ADV-related HO in Chinese chronic hepatitis B patients with long-term ADV treatment in Chinese and non-Chinese comparative case series. Methods: Retrieval of case reports was based on Pubmed, CNKI, Wan Fang and VIP databases using the key words adefovir dipivoxil, hypophosphatemia, osteomalacia and Fanconi syndrome. We divided patients into Chinese (C group) and Foreign (F group) groups according to their nationality. Comparisons involving demographics, clinical manifestations, tests, treatment and prognosis were conducted between the two groups. Results: Of the patients screened, 120 Chinese patients were identified in the C group, and 32 non-Chinese patients were identified in the F group. The average age of the C group was younger than that of the F group (51.89 years ±10.96 years versus 56.47 years ±11.36 years, t = - 2.084, P = 0.039). No significant difference was found in gender (male to female, 3.29:1 versus 3:1, χ 2 = 0.039, P = 0.844). Although there was no significant difference in the duration of ADV therapy before ostalgia onset, the C group tended to develop adverse events earlier, by 2-3 years, while the F group developed adverse events at 4-5 years (Z = - 1.517, P = 0.129). Prognosis was good after adjustment of the ADV dose and supplemental administration of phosphate and calcitriol. Time to resolution of tubular dysfunction was commenced at the first month, and Chinese patients were more prone to recover in the first 3 months than non-Chinese patients (91.3% of patients in the C group versus 56.3% in the F group, Z = - 3.013, P = 0.003). Conclusions: Sufficient attention is required for middle-aged males before and during exposure to long-term ADV therapy, regardless of nationality. The clinical picture, laboratory and radiograph alterations are important clues for those patients and are usually characterized by polyarthralgia, renal tubular dysfunction and mineralization defects. Implementation of an early renal tubular injury index is recommended for patients with higher risk, which would prevent further renal injury.

Osteomalacia Induced by Long-Term Low-Dose Adefovir Dipivoxil: Clinical Characteristics and Genetic Predictors

Follow-Up of Adefovir Dipivoxil Induced Osteomalacia: Clinical Characteristics and Genetic Predictors

Clinical Analysis of 11 Cases of Adefovir Dipivoxil-induced Renal Hypophosphatemia and Osteomalacia

Nephrogenic Hypophosphatemic Osteomalacia During Adefovir Monotherapy for Chronic Hepatitis B Monoinfection.

Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series

Adefovir Dipivoxil Induced Hypophosphatemic Osteomalacia:Report of Two Cases

Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report

The clinical and pathological features of adefovir dipivoxil-related renal impairment

Persistently Elevated Urine β2-MG and Decreased BMD in a Patient with ADV-induced Hypophosphatemic Osteomalacia and Fanconi’s Syndrome After Drug Withdrawal

Hypophosphataemic osteomalacia in patients on adefovir dipivoxil

Early Kidney Injury During Long-Term Adefovir Dipivoxil Therapy for Chronic Hepatitis B.

Clinical management of hypophosphatemic osteomalacia induced by adefovir and tenofovir: Insights from a case report

A Retrospective Analysis of Adverse Drug Reaction Caused by Adefovir Dipivoxil

Bilateral Femoral Head Necrosis And Pathological Fractures Resulted From Fanconi Syndrome Due To Adefovir Dipivoxil Treatment: A Case Report And Systematic Analysis Of 7 Cases

Fanconi syndrome complicated with spinal cord diseases and peripheral neuropathy related to adefovir dipivoxil

Renal Safety of Adefovir Dipivoxil for Two-Year Treatment in Chinese Patients with Chronic Hepatitis B

[Marked improvement in renal tubular markers after switching from adefovir to tenofovir alafenamide in a case of Fanconi syndrome diagnosed through high ALP levels]

Neutrophil Gelatinase-Associated Lipocalin Accurately Predicts Renal Tubular Injury in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogs.

SAA1 Gene Polymorphisms in Osteoporosis Patients

Efficacy of adefovir dipivoxil in treatment of chronic hepatitis B patients with lamivudine resistance

Biopsy-proven Nephrotoxicity Induced by Adefovir